Eledon Pharmaceuticals, Inc. (ELDN): Net Income
-$45.62M
Year ended 2025-12-31
-$98.56M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$45.62M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$36.18M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$116.54M | n/m | 2025-08-14, From 2023-01-01 |
| 2022-12-31 | -$87.97M | n/m | 2024-08-19, From 2022-01-01 |
| 2021-12-31 | -$34.51M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$22.81M | n/m | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | -$16.01M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$14.06M | n/m | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | -$13.12M | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$5.66M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$45.09M | n/m | 2017-03-03, From 2015-01-01 |
| 2014-12-31 | -$23.30M | n/m | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | -$15.72M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$9.65M | n/a | 2015-03-26, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | -$45.62M | n/m |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | -$78.54M | n/m |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | -$59.85M | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $9.88M | -44.8% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$170.37M | n/m |
| PepGen Inc. (PEPG) | 2025-12-31 | -$89.66M | n/m |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | -$6.00M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $4.82M | n/m |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | -$34.66M | n/m |
Compare ELDN, CRBP, CLYM, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗